CapsoVision, Inc. (CV)

Market Cap	199.37M
Revenue (ttm)	12.04M
Net Income (ttm)	-21.07M
Shares Out	46.47M
EPS (ttm)	-3.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,455
Open	4.280
Previous Close	4.220
Day's Range	4.180 - 4.300
52-Week Range	3.490 - 5.720
Beta	n/a
Analysts	Buy
Price Target	5.00 (+16.55%)
Earnings Date	n/a

About NVRO

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). The company also provides CapsoCloud cloud-based software-as-a-service ecosystem as a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 2, 2025
• Employees: 90
• Stock Exchange: NASDAQ
• Ticker Symbol: CV
• Website: https://capsovision.com

Analyst Summary

According to one analyst, the rating for CV stock is "Buy" and the 12-month stock price target is $5.0.

Price Target

$5.0

(16.55% upside)

Analyst Consensus: Buy